Phase I clinical trial that harnesses CAR-T immunotherapy

City of Hope currently has many clinical trials in progress, a number of which address malignant brain tumors. Our brain tumor team is currently enrolling patients with recurrent brain tumors for a new Phase I clinical trial that harnesses CAR-T immunotherapy to fight advanced brain cancers. This trial uses a patient’s own modified T cells to fight their tumors and is designed to target the tumor head-on by delivering the treatment directly into the brain. 
 
 
 
 
You can learn more about this clinical trial online at ClinicalTrials.gov.